Skip to main content
ConvictionStocks
ScreenerEarningsLearn
1D1W1M3M1Y5YMAX
                      

Healthcare

Nkarta, Inc.

NKTX
$3.23+10.62%

Price is delayed.

Add to watchlist

About Nkarta, Inc.

Nkarta is a company developing new medicines made from natural killer cells, which are immune cells that fight disease. The company is testing its main treatment, called NKX019, in early human trials for several autoimmune diseases including lupus and a related kidney condition. The company was founded in 2015 and is based in South San Francisco.

1D1W1M3M1Y5YMAX
                      
Loading chart...

Chart powered by TradingView Lightweight Charts

Members only

Full research is for ConvictionStocks members

Members read the rest of this page. Where we have it for this company, that is:

  • What each number means, in plain English, with the Wall Street name where the two differ.
  • A plain-English summary of the company.
  • How many analysts cover it, and the count behind each rating.
  • Recent news, dated.
Get full accessSee a sample company page in full

Get the free weekly market digest

The week's biggest movers, every Sunday. No spam.

                                                                                          

Look up another company

No tickers found

Related Research

More Healthcare stocks to explore

NVS

Novartis AG

AMGN

Amgen Inc.

NVO

Novo Nordisk A/S

ABT
ConvictionStocks logo

Plain-English investing education for people who want to understand what they own.

Product

  • Features
  • Pricing
  • Screener
  • Earnings

Resources

  • Learn
  • Glossary

Company

  • Terms of Service
  • Privacy Policy
  • Contact us

ConvictionStocks is for informational purposes only and does not constitute financial advice. We are not a registered investment advisor. Past performance does not guarantee future results.

© 2026 ConvictionStocks. All rights reserved.

Abbott Laboratories

PFE

Pfizer Inc.